Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Annelie Musters"'
Autor:
Eva Knöps, Phyllis Spuls, Ruben Duijnhoven, Marcel Dijkgraaf, Marit van Barreveld, Bernd Arents, Annefloor van Enst, Floor Garritsen, Maruschka Merkus, Pina Middelkamp-Hup, Annelie Musters, Angela Bosma, Ariënna Hyseni, Jitske Dijkstra, Dirk Jan Hijnen, Louise Gerbens
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, as current evidence is of low c
Externí odkaz:
https://doaj.org/article/d69cfcf25ead45bdae8a8910754204b1
Autor:
Koos van Dam, Adriaan Volkers, Luuk Wieske, Eileen Stalman, Laura Kummer, Zoe van kempen, Joep Killestein, Sander Tas, Laura Boekel, Gertjan Wolbink, Anneke van der Kooi, Joost Raaphorst, Bart Takkenberg, Geert D'Haens, Phyllis Spuls, Marcel Bekkenk, Annelie Musters, Nicoline Post, Angela Bosma, Marc Hilhorst, Yosta Vegting, Frederike Bemelman, Alexandre Voskuyl, Bo Broens, Agner Parra Sanchez, Cecile van Els, Jelle de Wit, Abraham Rutgers, Karina de Leeuw, Barbara Horvath, Jan Verschuuren, Annabel Ruiter, Lotte van Ouwerkerk, Diane van der Woude, Renee Allaart, Onno Teng, Pieter van Paassen, Matthias Busch, Papay Jallah, Esther Brusse, Pieter van Doorn, Adaja Baars, DirkJan Hijnen, Corine Schreurs, Ludo van der Pol, Stephan Goedee, Maurice Steenhuis, Sofie Keijzer, Jim Keijser, Olvi Cristianawati, Anja ten Brinke, Niels Verstegen, Marieke van Ham, Theo Rispens, Taco Kuijpers, Mark Lowenberg, Filip Eftimov
Publikováno v:
BMC Infectious Diseases, 23:332. BMC
Background: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate long-term hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5596c6d93583cc96daba93e3e6157aae
https://doi.org/10.21203/rs.3.rs-2272601/v1
https://doi.org/10.21203/rs.3.rs-2272601/v1
Autor:
Gayle van der Kraaij, Celine Busard, Juul van den Reek, Stef Menting, Annelie Musters, Barbara Hutten, Menno de Rie, Wouter Ouwerkerk, Sun-Jine van Bezooijen, Errol Prens, Theo Rispens, Annick de Vries, Elke de Jong, Wim de Kort, Jo Lambert, Martijn van Doorn, Phyllis Spuls
Publikováno v:
Journal of Investigative Dermatology, 142(9), 2375-+. Nature Publishing Group
Journal of investigative dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
van der Kraaij, G, Busard, C, van den Reek, J, Menting, S, Musters, A, Hutten, B, de Rie, M, Ouwerkerk, W, van Bezooijen, S-J, Prens, E, Rispens, T, de Vries, A, de Jong, E, de Kort, W, Lambert, J, van Doorn, M & Spuls, P 2022, ' Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis : First-Year Results of a Single-Blind Randomized Controlled Trial ', Journal of Investigative Dermatology, vol. 142, no. 9, pp. 2375-2383.e6 . https://doi.org/10.1016/j.jid.2022.01.033
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Journal of Investigative Dermatology, 142, 9, pp. 2375-2383.e6
Journal of Investigative Dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
Journal of Investigative Dermatology, 142, 2375-2383.e6
Journal of investigative dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
van der Kraaij, G, Busard, C, van den Reek, J, Menting, S, Musters, A, Hutten, B, de Rie, M, Ouwerkerk, W, van Bezooijen, S-J, Prens, E, Rispens, T, de Vries, A, de Jong, E, de Kort, W, Lambert, J, van Doorn, M & Spuls, P 2022, ' Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis : First-Year Results of a Single-Blind Randomized Controlled Trial ', Journal of Investigative Dermatology, vol. 142, no. 9, pp. 2375-2383.e6 . https://doi.org/10.1016/j.jid.2022.01.033
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Journal of Investigative Dermatology, 142, 9, pp. 2375-2383.e6
Journal of Investigative Dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
Journal of Investigative Dermatology, 142, 2375-2383.e6
Introduction: Adalimumab is normally prescribed with methotrexate (MTX) in rheumatoid arthritis given the enhanced treatment effect and reduced antidrug antibody formation compared with adalimumab monotherapy (ADL). In psoriasis, the long-term treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705059c885874d621eb5876dff42e1d0
https://pure.eur.nl/en/publications/9e5ee111-9e22-462d-97c4-41566601aeb1
https://pure.eur.nl/en/publications/9e5ee111-9e22-462d-97c4-41566601aeb1